• 3-4年经验
  • 博士
  • 招若干人
  • 11-09 发布

职位描述

职位描述: About the department Novo Nordisk (NN) is one of the world’s leaders in diabetes care with a growing business in other treatment areas like obesity and hemophilia. NN employs approximately 42,000 people in 77 countries and markets its products in more than 165 countries. Novo Nordisk research centre in Beijing is established in 1999 and is the first research centre established by a foreign pharma in China. We are a fully integrated research unit of NN and has close cross-functional collaboration with NN headquarter in Denmark and other NN research centres. Our mission is to leverage our expertise in protein technology, pharmacology, and disease models to progress NN’s research pipeline within diabetes, obesity, and hemophilia. Discovery Biology China (DBC) is one of the research units in Novo Nordisk China R&D with focus on 1) being an integrated part of the global research engine to progress NN project pipeline in diabetes/obesity; 2) contributing to innovation with our strong pharmacology platform and target discovery and validation platform. The open position is in Biology and Bioanalysis department of DBC, with responsibilities described below. The position We are looking for a motivated, flexible, highly productive individual who is seeking a cross-functional collaborative research environment. A successful candidate is expected to exhibit a combination of molecular/in vitro biology experience, demonstrated scientific understanding of metabolic diseases, especially diabetes, obesity and/or cardiovascular diseases, and proven ability to acquire new knowledge and skills quickly. Responsibilities include: - Design and perform research in target discovery and validation - Screening assay development - Establish state-of-the art cell based assay to support protein therapeutics identification for diabetes/obesity - Propose, explore and implement relevant new technology in the field of molecular biology/in vitro biology - Supervise research associates - Present results to senior management and other research stuff - Scouting within diabetes/obesity/CVD for new project idea initiation and evaluation - May lead early stage drug discovery effort Qualifications - Ph.D. in biology or relevant areas with minimum 2-3 years of postdoctoral training experience - Proven record of productivity - Independent and innovative researcher - Must have demonstrated knowledge in the field of metabolic diseases (diabetes, obesity, cardiovascular disease, etc.) - Strong written and verbal communication skills, fluent in English, overseas experience preferred - Excellent team player and collaboration skills - Industrial experience preferred Working at Novo Nordisk You need to have good communication and collaboration skills as you will play a key role in representing your expertise area in global project teams and towards colleagues at the other research sites. You are flexible, open to new ideas, ambitious, innovative and result oriented. You have a lot of individual responsibility with a high degree of personal impact in the projects. You are able to meet deadlines and keep overview. Furthermore, you are fluent in English. Title and compensation will be commensurate with the applicant’s qualifications and based on benchmark in China. 职能类别: 生物工程/生物制药

联系方式

公司信息

诺和诺德在中国 诺和诺德是中国市场的领导者,一直以改变为己任。诺和诺德(中国)制药有限公司于1994年成立,二十几年来业务一直保持强劲增长。公司总部设在北京,产品和服务遍及全国所有省、直辖市及中国港澳台地区。截至2016年底,诺和诺德在华员工总数4356人。诺和诺德是在中国建立研发中心的生物制药公司。位于北京的研发中心是诺和诺德全球研发体系的组成部分,致力于与总部合作研发新产品及新生产工艺。诺和诺德在中国的生产厂位于天津,是公司的国际化战略生产基地。公司对工厂提供了大量的资金投入和技术支持,向全球以及中国市场供应产品。诺和诺德在中国的不断发展反映了公司对中国市场的承诺。 Novo Nordisk in China As the leader in the Chinese market, Novo Nordisk has always been committed to Changing. Founded in 1994 and headquartered in Beijing, Novo Nordisk’s presence in China has been growing for more than 20 years.Headquartered in Beijing, providing products and services across mainland China as well as Hong Kong, Macau and Taiwan of China. As of the end of 2016, Novo Nordisk employed over 4,356 employees in China.

猎才二维码